Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 947-952, May 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, R. P.
Right arrow Articles by Triolo, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, R. P.
Right arrow Articles by Triolo, A. J.

Effect of the Organophosphate Insecticide Parathion and Its Active Metabolite Paraoxon on the Metabolism of Benzo(a)pyrene in the Rat1

Rocky P. Weber, Julius M. Coon and Anthony J. Triolo2

Department of Pharmacology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Pretreatment of rats with the organophosphate insecticide parathion (0.7 mg/kg) and its active metabolite paraoxon (0.3 mg/kg) i.p. once daily for 5 days before the i.v. administration of carbon-labeled benzo(a)pyrene (BP-14C) on the 6th day decreased the rate of biliary excretion of radioactive metabolites derived from BP-14C. Decreased bile flow did not account for this finding since the rate of bile flow was not affected by treatment with these organophosphates. Parathion and paraoxon treatment increased the amount of unchanged BP-14C and decreased the amount of BP-14C metabolites in liver and small intestine but not in lung, when measured 95 min after i.v. administration BP-14C. In vitro studies of the hydroxylation of benzo(a)-pyrene (BP) showed a decreased activity of BP hydroxylase in liver, small intestine, and lung of rats previously treated with these organophosphates. BP hydroxylase activity was also inhibited when parathion or paraoxon was added directly to the incubation medium containing homogenates of liver, small intestine, and lung. These findings indicate that both parathion and paraoxon inhibit the in vivo and in vitro metabolism of BP.

1 This investigation was supported by USPHS General Research Support Grant RR-5415 and USPHS Grant ES00507. A preliminary report of this study was given previously (20).

2 To whom requests for reprints should be sent, at Department of Pharmacology, Thomas Jefferson University, 1020 Locust Street, Philadelphia, Pa. 19107.

Received 11/ 2/73. Accepted 1/25/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.